Skip to main content
Glama

Biosamples

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, so the agent knows this is a safe, non-destructive lookup. The description adds genuinely useful behavior beyond that: parallel fan-out across sources, resolved_from/resolved_to for name resolution, the sources_used/sources_failed self-reporting mechanism, and GNU stylized notes for empty sections. A 4 rather than 5 because it doesn't detail rate limits or latency expectations, but it does cover the important failure modes and data semantics.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Dense but valuable: every clause adds a distinct fact (one-call fan-out, accepted inputs, resolution behavior, empty-section semantics, source reporting). The description is long and packed, but that density is justified for a tool that covers many sources and edge cases. It loses one point because the stream-of-consciousness style with many parentheticals could be more scannable with bullets or clearer sentence boundaries.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the large number of data sources, input variants, and edge cases, the description covers the essentials: inputs, resolution, private-company behavior, empty results, and source status reporting. It could add response shape details (e.g., JSON structure of basics/filings), but an output schema could cover structure and the description already explains semantics. A 4 is appropriate for the complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema descriptions already cover the two parameters at 100%, including the interchangeability of type values. The description adds context beyond the schema: name resolution behavior, zero-padded CIK requirement, private-company behavior, and ticker/name examples. That extra context justifies a 4 rather than baseline 3; a 5 would require additional parameter interaction guidance, like precedence between name and ticker if both somehow conflict, which isn't relevant here.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a rich set of concrete example queries and immediately states the core function: a full cross-source profile of a US public company in one parallel call. It distinguishes itself from single-pack lookups and sibling tools like resolve_entity by specifying what it fans out across and what it returns.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says ALWAYS PREFER over chaining single-pack lookups for holistic views, lists when it applies (US public company), and explains edge cases like private companies returning resolved:false with notes. It also notes that an empty section is real 'no data', not a bug, which prevents false-negative troubleshooting.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Biosamples toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools have unclear boundaries: ask_pipeworx_beta is explicitly identical to ask_pipeworx right now, and ask_pipeworx_grounded is a subtle behavioral variant, creating a real selection hazard. The six polymarket_* tools also blur together (edges vs arbitrage vs fill_risk vs kalshi_spread all relate to finding and acting on mispricings), and scan_competitor_ai_presence is largely a wrapper over ai_visibility_check.

Naming Consistency3/5

All names are snake_case and several families share clear prefixes (ask_pipeworx, polymarket_*, pipeworx_*, scan_*), which keeps the set readable. However, the set mixes verb-first names (get_sample, compare_entities, resolve_entity) with noun-first names (entity_profile, bet_research, recent_changes, polymarket_edges), and the _beta suffix signals a status while _grounded signals a behavior, so the pattern is not predictable.

Tool Count2/5

33 tools is above the threshold where a tool set starts to feel bloated, and for a server named 'Biosamples' it is an extreme scope mismatch: 31 of 33 tools relate to Pipeworx data routing, prediction markets, memory, or subscriptions rather than biological samples. The count is also padded with near-duplicates such as ask_pipeworx_beta and scan_competitor_ai_presence.

Completeness2/5

Against the server's stated identity, the BioSamples surface is severely thin: only search_samples and get_sample exist, with no batch retrieval, project/group navigation, sample-group hierarchy, or submission/update path. The 31 unrelated tools do not fill this gap — they serve a completely different domain, so an agent using this server for biological sample data will hit dead ends.

Resources